Cell culture compositions with antioxidants and methods for polypeptide production

US10017732B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10017732-B2
Application numberUS-201414211416-A
CountryUS
Kind codeB2
Filing dateMar 14, 2014
Priority dateMar 15, 2013
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Cell culture media comprising antioxidants are provided herein as are methods of using the media for cell culturing and polypeptide production from cells. Compositions comprising polypeptides, such as therapeutic polypeptides, produced by the methods herein are also provided.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of producing a recombinant antibody composition with reduced color intensity, comprising the steps of: culturing a cell comprising a nucleic acid encoding the recombinant antibody in a cell culture medium, wherein the cell culture medium comprises one or more of components (a)-(d): (a) hypotaurine, (b) s-carboxymethylcysteine, (c) butylated hydroxyanisole, and (d) quercitrin hydrate; and producing the recombinant antibody; wherein the cell culture medium comprising one or more of components (a)-(d) reduces the color intensity of a composition comprising the recombinant antibody produced by the cell as compared to a composition comprising the recombinant antibody produced by the cell cultured in a cell culture medium that does not comprise one or more of components (a)-(d). 2. The method of claim 1 , wherein the recombinant antibody is an antibody fragment. 3. The method of claim 1 , wherein the recombinant antibody is an IgG1 antibody. 4. The method of claim 1 , 2 or 3 , wherein the recombinant antibody is secreted into the cell culture medium. 5. The method of claim 1 , further comprising the step of recovering the recombinant antibody from the cell culture medium comprising one or more of components (a)-(d). 6. The method of claim 5 , wherein a composition comprising the recovered recombinant antibody is a liquid composition or a non-liquid composition. 7. The method of claim 6 , wherein the composition comprising the recovered recombinant antibody appears as a colorless or slightly colored liquid. 8. The method of claim 1 , wherein the cell culture medium comprising one or more of components (a)-(d) reduces the color intensity of a composition comprising the recombinant antibody produced by the cells by at least about 0.1% as compared to a composition comprising the recombinant antibody produced by the cell cultured in a cell culture medium that does not comprise the one or more of components (a)-(d). 9. The method of claim 1 , wherein the cell culture medium comprising one or more of components (a)-(d) reduces the color intensity of a composition comprising the recombinant antibody produced by the cells by about 5% to about 50% as compared to a composition comprising the recombinant antibody produced by the cell cultured in a cell culture medium that does not comprise the one or more of components (a)-(d). 10. The method of claim 1 , wherein the cell culture medium comprises the one or more components (a)-(d) in an amount selected from: (a) hypotaurine at a concentration from at least about 0.0001 mM; (b) s-carboxymethylcysteine at a concentration from at least about 0.0001 mM; (c) butylated hydroxyanisole at a concentration from at least about 0.0001 mM; and (d) quercitrin hydrate at a concentration from at least about 0.0001 mM. 11. The method of claim 10 , wherein the cell culture medium comprises hypotaurine at a concentration from about 2.0 mM to about 50.0 mM. 12. The method of claim 10 , wherein the cell culture medium comprises s-carboxymethylcysteine at a concentration from about 8.0 mM to about 12.0 mM. 13. The method of claim 10 , wherein the cell culture medium comprises butylated hydroxyanisole at a concentration from about 0.025 mM to about 0.040 mM. 14. The method of claim 10 , wherein the cell culture medium comprises quercitrin hydrate at a concentration from about 0.010 mM to about 0.020 mM. 15. The method of claim 1 , wherein the cell culture medium is a chemically defined cell culture medium. 16. The method of claim 1 , wherein the cell culture medium is a chemically undefined cell culture medium. 17. The method of claim 1 , wherein the cell culture medium is a basal cell culture medium. 18. The method of claim 1 , wherein the cell culture medium is a feed cell culture medium. 19. The method of claim 1 , wherein the cell is contacted with the cell culture medium during the cell's growth phase. 20. The method of claim 1 , wherein the cell is contacted with the cell culture medium during the cell's production phase. 21. The method of claim 1 , wherein the one or more of components (a)-(d) is added to the cell culture medium on at least one day of a cell culture cycle. 22. The method of claim 1 , wherein the one or more of components (a)-(d) is added to the cell culture medium on day 0 of a 14 day cell culture cycle. 23. The method of claim 1 , wherein the cell is a mammalian cell. 24. The method of claim 23 , wherein the mammalian cell is a Chinese Hamster Ovary (CHO) cell.

Assignees

Inventors

Classifications

  • C12N5/0018Primary

    Culture media for cell or tissue culture (media for specific animal cell type C12N5/06) · CPC title

  • Thiols, e.g. mercaptoethanol · CPC title

  • Organic components · CPC title

  • other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine · CPC title

  • Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10017732B2 cover?
Cell culture media comprising antioxidants are provided herein as are methods of using the media for cell culturing and polypeptide production from cells. Compositions comprising polypeptides, such as therapeutic polypeptides, produced by the methods herein are also provided.
Who is the assignee on this patent?
Genentech Inc
What technology area does this patent fall under?
Primary CPC classification C12N5/0018. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).